Stay updated with breaking news from Babakj mehrara. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Researchers Uncover Potential Causes of Chronic Allergy Inflammation miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
PureTech Initiates Phase 2a trial of LYT-100 (Deupirfenidone) in Lymphedema businesswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businesswire.com Daily Mail and Mail on Sunday newspapers.
Study will further evaluate safety and tolerability of LYT-100 and explore clinical efficacy endpoints in patients with breast-cancer related, upper limb secondary lymphedema
Previously announced results from multiple ascending dose and food effect study in healthy volunteers demonstrated favorable tolerability and pharmacokinetic proof-of-concept for LYT-100
A separate Phase 2 study evaluating LYT-100 in Long COVID respiratory complications and related sequelae was recently initiated
PureTech Health plc (LSE: PRTC, Nasdaq: PRTC) ( PureTech or the Company ), a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, today announced the initiation of a Phase 2a proof-of-concept study of LYT-100 (deupirfenidone) in patients with breast cancer-r ....